Mark D. Lim (@markdlim) header
Mark D. Lim (@markdlim) profile picture

VP Research, Discovery, Innovation @ASNKidney; alum: global health @ASMicrobiology & @GatesFoundation, innovation @FasterCures @DARPA @theNCI @aaas_stpf

Washington, DC
Joined June 2013
Excited for our team’s first in-person event tomorrow. Here’s a photo of the team with some of our VIP speakers @DavidRushOnline, John Sedor, Linda Fried, and Joe Bonventre. #sockittokidneydisease
1
4
171
How can innovators, researchers, and regulators learn from people with kidney diseases? How can community partners raise disease awareness and encourage clinical trial participation? Join the @KidneyHealthIn community this Weds at 3:00 pm EDT. Register: us06web.zoom.us/webinar/regi…
1
4
As part of the #DIA2022 opening session, Ken Getz updates the drug development landscape, highlighting increased volume of data and trends in the regulatory pipeline via @CISCRP data
1
3
ASN president @SusanQuaggin shares why innovation, clinical trials and health equity are simultaneously needed to address kidney diseases as a global public health problem at #KidneyWk youtube.com/watch?v=mNlqxaCk…
1
#Clinicaltrial diversity requires understanding a community that is not just defined by color, race, ethnicity but aspects of humanity that bring people together in an environment of trust and respect. Watch @KidneyHealthIn plenary discussion youtube.com/watch?v=kDw6rUdw…
Really honored at the opportunity to share the history and direction of @Kidney_X & the Kidney Health Initiative's efforts to accelerate innovations for people with kidney diseases, as part of @KidneyPatients #GlobalKidney2021 youtube.com/watch?v=L2yDi6aO…
2
3
Dr Brigitte Schiller shares @satellitehealth process for providing #dialysis patients with #COVID19 #vaccine
1
4
Dr Brigitte Schiller shares sources of #COVID19 #vaccine hesitancy adding "The distrust is real"
Dr Brigitte Schiller shares prioritization of #COVID19 #vaccine: #Dialysis facility employees are group 1a with patients undergoing dialysis in group 1c
1
Dr T Alp Ikizler finishes his discussion on opportunities to increase the number of #dialysis patients receiving #COVID19 #vaccine
Dr T Alp Ikizler shares several efforts for including #dialysis patients in #COVID19 #vaccine distribution and #clinicaltrials
1
Dr T Alp Ikizler emphasizes that none of the #COVID19 #vaccine data evaluated people with kidney disease, except for a small cohort in @pfizer trial, leaving a couple of open questions
1